vimarsana.com


Operator
Greetings and welcome to the Edwards Lifesciences First Quarter 2021 Results Conference Call. [Operator Instructions] Please note that this conference is being recorded.
I will now turn the conference over to our host, Mark Wilterding, Vice President of Investor Relations. Thank you. You may begin.
Mark Wilterding --
Vice President, Investor Relations
Thank you, Diego. Good afternoon and thank you for joining us. With me on today's call are Mike Mussallem, Chairman and Chief Executive Officer; and Scott Ullem, Chief Financial Officer.
Just after the close of regular trading, Edwards Lifesciences released first quarter 2021 financial results. During today's call, management will discuss those results included in the press release and accompanying financial statements and then use the remaining time for Q&A.

Related Keywords

Japan ,Mike Mussallem ,Michaela Mussallem ,Edwards Lifesciences ,Mark Wilterding ,Scott Ullem ,Edwards Lifesciences Corp ,Edwards Lifesciences First Quarter ,Vice President ,Chief Executive Officer ,Chief Financial ,Chief Executive ,Transcatheter Mitral ,Tricuspid Therapies ,Transcatheter Mitral Replacement ,ஜப்பான் ,மைக் முசல்லம் ,மைக்கேலா முசல்லம் ,எட்வர்ட்ஸ் ஆயுள் அறிவியல் ,எட்வர்ட்ஸ் ஆயுள் அறிவியல் கார்ப் ,எட்வர்ட்ஸ் ஆயுள் அறிவியல் முதல் காலாண்டு ,துணை ப்ரெஸிடெஂட் ,தலைமை நிர்வாகி அதிகாரி ,தலைமை நிதி ,தலைமை நிர்வாகி ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.